# CPT 87624

> Not at a published national rate. CPT 87624 carries status X (statutory exclusion) in the Q1 2021 release. The statutory definition of physician services does not include this item. Treat the blank amount as unpriced, not as $0.

## What it is

A molecular test on a cervical sample that looks for the human papillomavirus strains most likely to lead to cancer, the group that includes types 16 and 18. It detects viral genetic material directly rather than judging how cells look under a microscope, so it answers whether a dangerous strain is present, not whether the cells have already changed. The low-risk types behind common genital warts are a different test.

## Selected release

- Release: Q1 2021 (2021 A)
- Effective: January 1 – March 31, 2021
- Status indicator: X
- Office (non-facility) national allowed amount: not published
- Facility national allowed amount: not published
- Sequestration: not applied

## RVUs and formula

- Work RVU: not published
- Office (non-facility) practice expense RVU: not published
- Facility practice expense RVU: not published
- Malpractice RVU: not published
- Conversion factor: 34.8931
- Formula: `(work_rvu × work_gpci + pe_rvu × pe_gpci + mp_rvu × mp_gpci) × conversion_factor`

## Source and citation

- Source: Physician relative value file (Q1 2021)
- CMS file: https://www.cms.gov/files/zip/rvu21a-updated-01052021.zip
- Parsed file: PPRRVU21_JAN.csv, row 15,283
- Canonical page: https://localishealth.com/cpt/87624/2015/A
- Release-specific citation URL: https://localishealth.com/cpt/87624/2021/A
- Last significant update: 2026-08-04T03:10:16+00:00